M. E. Kroll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. E. Kroll has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
M F G Murphy
Childhood Cancer Research Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LG, UK
5 shared publications- Charles A. Stiller
University of Oxford
4 shared publications L M Carpenter
Childhood Cancer Research Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LG, UK
4 shared publicationsC A Stiller
Childhood Cancer Research Group, Department of Paediatrics, University of Oxford, Richards Building, Oxford OX3 7LG, UK
3 shared publications- Felicity Murphy
Cancer Epidemiology Unit, Nuffield Department of Medicine, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford OX3 7LF, UK
2 shared publications J Green
Cancer Epidemiology Unit, Nuffield Department of Medicine, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford OX3 7LF, UK
2 shared publications
Latest Publications
- Open Access
- 2 May 2013
- Published by Springer Nature in British Journal of Cancer
- Vol. 108 (11) , 2390-2398
Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study
Greater adiposity and height have been associated with increased risk of haematological malignancies. Associations for disease subtypes are uncertain. A cohort of 1.3 million middle-aged UK women was recruited in 1996–2001 and followed for 10 years on average. Potential risk factors were assessed by questionnaire. Death, emigration, and incident cancer were ascertained by linkage to national registers. Adjusted relative risks were estimated by Cox regression. During follow-up, 9162 participants were diagnosed with lymphatic or haematopoietic cancers. Each 10 kg m−2 increase in body mass index was associated with relative risk of 1.20 (95% confidence interval: 1.13–1.28) for lymphoid and 1.37 (1.22–1.53) for myeloid malignancy (P=0.06 for heterogeneity); similarly, Hodgkin lymphoma 1.64 (1.21–2.21), diffuse large B-cell lymphoma 1.36 (1.17–1.58), plasma cell neoplasms 1.21 (1.06–1.39), acute myeloid leukaemia 1.47 (1.19–1.81), and myeloproliferative/myelodysplastic syndromes 1.32 (1.15–1.52). Each 10 cm increase in height was associated with relative risk of 1.21 (1.16–1.27) for lymphoid and 1.11 (1.02–1.21) for myeloid malignancy (P=0.07 for heterogeneity); similarly, mature T-cell malignancies 1.36 (1.03–1.79), diffuse large B-cell lymphoma 1.28 (1.14–1.43), follicular lymphoma 1.28 (1.13–1.44), plasma cell neoplasms 1.12 (1.01–1.24), chronic lymphocytic leukaemia/small lymphocytic lymphoma 1.23 (1.08–1.40), and acute myeloid leukaemia 1.22 (1.04–1.42). There was no significant heterogeneity between subtypes. In middle-aged women, greater body mass index and height were associated with modestly increased risks of many subtypes of haematological malignancy.
- 2 May 2013
- Published by Springer Nature in British Journal of Cancer
- Vol. 108 (11) , 2390-2398
Open AccessBody size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study
Greater adiposity and height have been associated with increased risk of haematological malignancies. Associations for disease subtypes are uncertain. A cohort of 1.3 million middle-aged UK women was recruited in 1996–2001 and followed for 10 years on average. Potential risk factors were assessed by questionnaire. Death, emigration, and incident cancer were ascertained by linkage to national registers. Adjusted relative risks were estimated by Cox regression. During follow-up, 9162 participants were diagnosed with lymphatic or haematopoietic cancers. Each 10 kg m−2 increase in body mass index was associated with relative risk of 1.20 (95% confidence interval: 1.13–1.28) for lymphoid and 1.37 (1.22–1.53) for myeloid malignancy (P=0.06 for heterogeneity); similarly, Hodgkin lymphoma 1.64 (1.21–2.21), diffuse large B-cell lymphoma 1.36 (1.17–1.58), plasma cell neoplasms 1.21 (1.06–1.39), acute myeloid leukaemia 1.47 (1.19–1.81), and myeloproliferative/myelodysplastic syndromes 1.32 (1.15–1.52). Each 10 cm increase in height was associated with relative risk of 1.21 (1.16–1.27) for lymphoid and 1.11 (1.02–1.21) for myeloid malignancy (P=0.07 for heterogeneity); similarly, mature T-cell malignancies 1.36 (1.03–1.79), diffuse large B-cell lymphoma 1.28 (1.14–1.43), follicular lymphoma 1.28 (1.13–1.44), plasma cell neoplasms 1.12 (1.01–1.24), chronic lymphocytic leukaemia/small lymphocytic lymphoma 1.23 (1.08–1.40), and acute myeloid leukaemia 1.22 (1.04–1.42). There was no significant heterogeneity between subtypes. In middle-aged women, greater body mass index and height were associated with modestly increased risks of many subtypes of haematological malignancy.
- Open Access
- 16 August 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (7) , 1159-1162
Effects of changes in diagnosis and registration on time trends in recorded childhood cancer incidence in Great Britain
Background: Methods: Results: Conclusion:
- 16 August 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (7) , 1159-1162
Open AccessEffects of changes in diagnosis and registration on time trends in recorded childhood cancer incidence in Great Britain
Background: Methods: Results: Conclusion:
- Open Access
- 9 August 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (5) , 879-887
Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study
Previous research suggests associations of lower alcohol intake and higher tobacco consumption with increased risks of haematological malignancy. The prospective Million Women Study provides sufficient power for reliable estimates of subtype-specific associations in women. Approximately 1.3 million middle-aged women were recruited in the United Kingdom during 1996–2001 and followed for death, emigration and cancer registration until 2009 (mean 10.3 years per woman); potential risk factors were assessed by questionnaire. Adjusted relative risks were estimated by Cox regression. During follow-up, 9162 incident cases of haematological malignancy were recorded, including 7047 lymphoid and 2072 myeloid cancers. Among predominantly moderate alcohol drinkers, higher intake was associated with lower risk of lymphoid malignancies, in particular diffuse large B-cell lymphoma (relative risk 0.85 per 10 g alcohol per day (95% confidence interval 0.75–0.96)), follicular lymphoma (0.86 (0.76–0.98)) and plasma cell neoplasms (0.86 (0.77–0.96)). Among never- and current smokers, higher cigarette consumption was associated with increased risk of Hodgkin lymphoma (1.45 per 10 cigarettes per day (1.22–1.72)), mature T-cell malignancies (1.38 (1.10–1.73)) and myeloproliferative/myelodysplastic disease (1.42 (1.31–1.55)). These findings confirm and extend existing evidence for associations of subtypes of haematological malignancy with two common exposures in women.
- 9 August 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (5) , 879-887
Open AccessAlcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study
Previous research suggests associations of lower alcohol intake and higher tobacco consumption with increased risks of haematological malignancy. The prospective Million Women Study provides sufficient power for reliable estimates of subtype-specific associations in women. Approximately 1.3 million middle-aged women were recruited in the United Kingdom during 1996–2001 and followed for death, emigration and cancer registration until 2009 (mean 10.3 years per woman); potential risk factors were assessed by questionnaire. Adjusted relative risks were estimated by Cox regression. During follow-up, 9162 incident cases of haematological malignancy were recorded, including 7047 lymphoid and 2072 myeloid cancers. Among predominantly moderate alcohol drinkers, higher intake was associated with lower risk of lymphoid malignancies, in particular diffuse large B-cell lymphoma (relative risk 0.85 per 10 g alcohol per day (95% confidence interval 0.75–0.96)), follicular lymphoma (0.86 (0.76–0.98)) and plasma cell neoplasms (0.86 (0.77–0.96)). Among never- and current smokers, higher cigarette consumption was associated with increased risk of Hodgkin lymphoma (1.45 per 10 cigarettes per day (1.22–1.72)), mature T-cell malignancies (1.38 (1.10–1.73)) and myeloproliferative/myelodysplastic disease (1.42 (1.31–1.55)). These findings confirm and extend existing evidence for associations of subtypes of haematological malignancy with two common exposures in women.
- Open Access
- 12 June 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (1) , 219-220
Reply to: ‘Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time’
- 12 June 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (1) , 219-220
Open AccessReply to: ‘Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time’
- Open Access
- 12 June 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (1) , 216
Reply: ‘Childhood leukaemia and socioeconomic status’
- 12 June 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (1) , 216
Open AccessReply: ‘Childhood leukaemia and socioeconomic status’
- Open Access
- 3 April 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (9) , 1556-1559
Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain
Recorded incidence of childhood acute lymphoblastic leukaemia tends to be lower in poorer communities. A ‘pre-emptive infection hypothesis’ proposes that some children with leukaemia die from infection without diagnosis of leukaemia. Various different blood abnormalities can occur in untreated leukaemia. Logistic regression was used to compare pre-treatment blood counts among children aged 1–13 years at recruitment to national clinical trials for acute lymphoblastic leukaemia during 1980–2002 (N=5601), grouped by address at diagnosis within Great Britain into quintiles of the 1991 Carstairs deprivation index. Children combining severe neutropenia (risk of serious infection) with relatively normal haemoglobin and platelet counts (lack of pallor and bleeding) were postulated to be at risk of dying from infection without leukaemia being suspected. A deficit of these children among diagnosed patients from poorer communities was predicted. As predicted, there was a deficit of children at risk of non-diagnosis (two-sided Ptrend=0.004; N=2009), and an excess of children with pallor (Ptrend=0.045; N=5535) and bleeding (Ptrend=0.036; N=5541), among cases from poorer communities. Under-diagnosis in poorer communities may have contributed to socioeconomic variation in recorded childhood acute lymphoblastic leukaemia incidence within Great Britain, and elsewhere. Implications for clinical practice and epidemiological studies should be considered.
- 3 April 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (9) , 1556-1559
Open AccessEvidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain
Recorded incidence of childhood acute lymphoblastic leukaemia tends to be lower in poorer communities. A ‘pre-emptive infection hypothesis’ proposes that some children with leukaemia die from infection without diagnosis of leukaemia. Various different blood abnormalities can occur in untreated leukaemia. Logistic regression was used to compare pre-treatment blood counts among children aged 1–13 years at recruitment to national clinical trials for acute lymphoblastic leukaemia during 1980–2002 (N=5601), grouped by address at diagnosis within Great Britain into quintiles of the 1991 Carstairs deprivation index. Children combining severe neutropenia (risk of serious infection) with relatively normal haemoglobin and platelet counts (lack of pallor and bleeding) were postulated to be at risk of dying from infection without leukaemia being suspected. A deficit of these children among diagnosed patients from poorer communities was predicted. As predicted, there was a deficit of children at risk of non-diagnosis (two-sided Ptrend=0.004; N=2009), and an excess of children with pallor (Ptrend=0.045; N=5535) and bleeding (Ptrend=0.036; N=5541), among cases from poorer communities. Under-diagnosis in poorer communities may have contributed to socioeconomic variation in recorded childhood acute lymphoblastic leukaemia incidence within Great Britain, and elsewhere. Implications for clinical practice and epidemiological studies should be considered.
- Open Access
- 25 October 2011
- Published by Springer Nature in British Journal of Cancer
- Vol. 105 (11) , 1783-1787
Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time
Background: Methods: Results: Conclusion:
- 25 October 2011
- Published by Springer Nature in British Journal of Cancer
- Vol. 105 (11) , 1783-1787
Open AccessChildhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time
Background: Methods: Results: Conclusion:
- Open Access
- 15 March 2011
- Published by Springer Nature in British Journal of Cancer
- Vol. 104 (7) , 1227-1233
Childhood cancer registration in Britain: capture-recapture estimates of completeness of ascertainment
Background: Methods: Results: Interpretation:
- 15 March 2011
- Published by Springer Nature in British Journal of Cancer
- Vol. 104 (7) , 1227-1233
Open AccessChildhood cancer registration in Britain: capture-recapture estimates of completeness of ascertainment
Background: Methods: Results: Interpretation:
- 7 October 2009
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 138 (1) , 89-91
Response to Letter to the Editor
- 7 October 2009
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 138 (1) , 89-91
Response to Letter to the Editor
- 1 January 1994
- p. 493-517
Childhood cancer.
Trends in incidence for the main types of childhood cancer are analysed using data from the British National Registry of Childhood Tumours; published reports from other registries are summarized. For registries included in Cancer Incidence in Five Continents, changes in rates reported in successive volumes are calculated and a number of problems in the interpretation of these results are identified. There is some limited evidence for a small increase in the incidence of ALL and more evidence for an increase in brain tumours, although the latter may be at least partly due to changes in diagnostic practice. There is limited, but good, evidence for an increase in the incidence of neuroblastoma. With two exceptions, there is no good evidence for any large increase in incidence for any form of childhood cancer in Britain or other countries over the past 20-30 years. The first exception is Kaposi's sarcoma in Uganda, the cumulative incidence in childhood increasing from fewer than 40 per million in 1968-1982 to more than 500 per million in 1989-1991. The second exception is thyroid carcinoma in Belarus, where the reported incidence probably represents about a 50-fold increase--to about 80 per million per year. This may, however, be at least partly a consequence of improved ascertainment following a screening programme. The results presented here suggest that no widespread important risk factor has been introduced over the past 30 years--unless some other similar factor has been simultaneously removed. Analyses of trends in mortality for childhood cancers are now mainly useful as a means of showing the impact of improved treatment methods.
- 1 January 1994
- p. 493-517
Childhood cancer.
Trends in incidence for the main types of childhood cancer are analysed using data from the British National Registry of Childhood Tumours; published reports from other registries are summarized. For registries included in Cancer Incidence in Five Continents, changes in rates reported in successive volumes are calculated and a number of problems in the interpretation of these results are identified. There is some limited evidence for a small increase in the incidence of ALL and more evidence for an increase in brain tumours, although the latter may be at least partly due to changes in diagnostic practice. There is limited, but good, evidence for an increase in the incidence of neuroblastoma. With two exceptions, there is no good evidence for any large increase in incidence for any form of childhood cancer in Britain or other countries over the past 20-30 years. The first exception is Kaposi's sarcoma in Uganda, the cumulative incidence in childhood increasing from fewer than 40 per million in 1968-1982 to more than 500 per million in 1989-1991. The second exception is thyroid carcinoma in Belarus, where the reported incidence probably represents about a 50-fold increase--to about 80 per million per year. This may, however, be at least partly a consequence of improved ascertainment following a screening programme. The results presented here suggest that no widespread important risk factor has been introduced over the past 30 years--unless some other similar factor has been simultaneously removed. Analyses of trends in mortality for childhood cancers are now mainly useful as a means of showing the impact of improved treatment methods.